Tetsu Inada

Tetsu Inada is a finance leader in the biotech and pharmaceuticals sector with a robust background spanning over two decades. They began their career as a management consultant at Arthur D. Little from 1997 to 2001, before moving on to key finance roles at Millennium Pharmaceuticals, Inc., including Director of Finance & Business Development. Tetsu served in several executive capacities at Takeda from 2021 to 2023, including Chief Financial Officer for both the Global Oncology and Global Vaccine Business Units. Currently, Tetsu is the Senior Vice President of Financial Planning & Analysis at Ardelyx, Inc. They hold a BS in Chemical Engineering from the Massachusetts Institute of Technology and an MBA in Financial Management from the MIT Sloan School of Management.